Isoclima launches CAREGARD glazing for healthcare security and privacy
Isoclima Specialty Glass introduced CAREGARD, a glazing system for healthcare spaces that combines forced-entry, ballistic and impact protection with options for daylight, observation and privacy. The product is aimed at hospitals, emergency departments and behavioral health facilities where different openings need different levels of security.
Why it matters: - Healthcare facilities often need different glazing performance at different openings, from clear staff sightlines in patient rooms to stronger forced-entry protection at entrances. - CAREGARD is designed to help project teams balance security, patient privacy, staff observation and natural daylight in one product family. - The product also addresses exterior-opening needs, including thermal, solar-control and weather-performance requirements.
What happened: - Isoclima Specialty Glass, LLC introduced CAREGARD, a purpose-built glazing solution for healthcare environments. - The U.S. subsidiary of Isoclima Group, headquartered in Este, Italy, said the product combines forced-entry resistance, ballistic protection and impact safety. - The company said CAREGARD is available for hospitals, emergency departments, patient observation rooms, intake areas and other healthcare spaces. - Isoclima said the product is also intended for psychiatric hospitals, behavioral health units, crisis stabilization centers, counseling and treatment spaces, and correctional healthcare facilities.
The details: - CAREGARD uses a symmetrical glass-clad polycarbonate construction with heat-treated glass on both exposed surfaces. - The glazing tested to ASTM F3561 Level 8 for forced-entry resistance. - The product also tested to NIJ Level IIA and Level II for ballistic resistance to handgun threats, with no penetration and no spall reported in testing. - Additional testing includes ASTM F1233-08 Glass Class 1.4 for body passage. - Additional testing includes 5-aa1 attack resistance for 16 minutes. - Additional testing includes H.P. White Level A using .38 Special ammunition, with no penetration. - Additional testing includes ANSI Z97.1 safety glazing requirements. - Additional testing includes CPSC 16 CFR 1201 safety glazing requirements. - Isoclima said project teams can choose a CAREGARD configuration based on the anticipated threat, opening location and project requirements. - CAREGARD is available in monolithic, laminated and insulating glass versions, plus custom configurations. - The standard product has a nominal thickness of about 9/16 inch. - The standard product weighs about 4.95 pounds per square foot. - Standard sizes range from 12 x 12 inches to 60 x 96 inches. - Available privacy and observation options include translucent interlayers, printed patterns, tinted or reflective glass, and switchable privacy glazing. - Exterior configurations can include insulating glass, low-E coatings, tinted glass, reflective glass and bird-friendly glazing options. - Isoclima said changes in glass makeup can affect thickness, weight and tested configurations, so requirements should be confirmed early in the design process. - More information is available in the company's announcement.
Between the lines: - The product reflects a broader push in healthcare design toward layered protection instead of a single security spec for an entire building. - The testing menu suggests CAREGARD is aimed at project teams that need to document performance across several threat scenarios and code requirements. - The privacy and daylight options show the product is meant to serve clinical workflow, not just perimeter security.
What's next: - Architects and facility teams will likely evaluate CAREGARD early in planning because changes in configuration can alter performance and physical specs. - Project teams can match the product to different openings across a facility instead of using one uniform glazing package.
The bottom line: - CAREGARD is Isoclima's attempt to package security, visibility and privacy into one healthcare-focused glazing platform.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Healthy Living Europe
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.